| Clinical practice guidelines for hepatocellular carcinoma: the Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update N Kokudo, N Takemura, K Hasegawa, T Takayama, S Kubo, M Shimada, ... Hepatology Research 49 (10), 1109-1113, 2019 | 468 | 2019 |
| Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma M Narita, E Hatano, S Arizono, A Miyagawa-Hayashino, H Isoda, ... Journal of gastroenterology 44, 793-798, 2009 | 408 | 2009 |
| Management of hepatocellular carcinoma in Japan: JSH consensus statements and recommendations 2021 update M Kudo, Y Kawamura, K Hasegawa, R Tateishi, K Kariyama, S Shiina, ... Liver cancer 10 (3), 181-223, 2021 | 388 | 2021 |
| Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis K Taura, S De Minicis, E Seki, E Hatano, K Iwaisako, CH Osterreicher, ... Gastroenterology 135 (5), 1729-1738, 2008 | 324 | 2008 |
| c‐Jun‐N‐terminal kinase drives cyclin D1 expression and proliferation during liver regeneration RF Schwabe, CA Bradham, T Uehara, E Hatano, BL Bennett, ... Hepatology 37 (4), 824-832, 2003 | 302 | 2003 |
| Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study T Takahara, G Wakabayashi, T Beppu, A Aihara, K Hasegawa, N Gotohda, ... Journal of Hepato‐Biliary‐Pancreatic Sciences 22 (10), 721-727, 2015 | 275 | 2015 |
| Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a … M Kudo, K Ueshima, O Yokosuka, S Ogasawara, S Obi, N Izumi, H Aikata, ... The lancet Gastroenterology & hepatology 3 (6), 424-432, 2018 | 261 | 2018 |
| Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications S Hasegawa, I Ikai, H Fujii, E Hatano, Y Shimahara World journal of surgery 31, 1258-1265, 2007 | 246 | 2007 |
| CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury N Tamaki, E Hatano, K Taura, M Tada, Y Kodama, T Nitta, K Iwaisako, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 294 (2 …, 2008 | 236 | 2008 |
| The NF90-NF45 complex functions as a negative regulator in the microRNA processing pathway S Sakamoto, K Aoki, T Higuchi, H Todaka, K Morisawa, N Tamaki, ... Molecular and cellular biology 29 (13), 3754-3769, 2009 | 231 | 2009 |
| Fluorine-18 fluorodeoxyglucose positron emission tomography predicts tumor differentiation, P-glycoprotein expression, and outcome after resection in hepatocellular carcinoma S Seo, E Hatano, T Higashi, T Hara, M Tada, N Tamaki, K Iwaisako, I Ikai, ... Clinical cancer research 13 (2), 427-433, 2007 | 229 | 2007 |
| A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin®) in cancer patients M Kanai, Y Otsuka, K Otsuka, M Sato, T Nishimura, Y Mori, M Kawaguchi, ... Cancer chemotherapy and pharmacology 71, 1521-1530, 2013 | 223 | 2013 |
| NF-κB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-α–and Fas-mediated apoptosis E Hatano, BL Bennett, AM Manning, T Qian, JJ Lemasters, DA Brenner Gastroenterology 120 (5), 1251-1262, 2001 | 210 | 2001 |
| A nomogram predicting disease‐free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for … T Beppu, Y Sakamoto, K Hasegawa, G Honda, K Tanaka, Y Kotera, ... Journal of Hepato‐Biliary‐Pancreatic Sciences 19 (1), 72-84, 2012 | 192 | 2012 |
| Randomized phase III study of gemcitabine, cisplatin plus S-1 (GCS) versus gemcitabine, cisplatin (GC) for advanced biliary tract cancer (KHBO1401-MITSUBA) D Sakai, M Kanai, S Kobayashi, H Eguchi, H Baba, S Seo, A Taketomi, ... Annals of Oncology 29, viii205, 2018 | 183* | 2018 |
| The mitochondrial permeability transition augments Fas-induced apoptosis in mouse hepatocytes E Hatano, CA Bradham, A Stark, Y Iimuro, JJ Lemasters, DA Brenner Journal of Biological Chemistry 275 (16), 11814-11823, 2000 | 177 | 2000 |
| Akt protects mouse hepatocytes from TNF-α-and Fas-mediated apoptosis through NK-κB activation E Hatano, DA Brenner American Journal of Physiology-Gastrointestinal and Liver Physiology 281 (6 …, 2001 | 175 | 2001 |
| Keratin 19, a cancer stem cell marker in human hepatocellular carcinoma T Kawai, K Yasuchika, T Ishii, H Katayama, EY Yoshitoshi, S Ogiso, S Kita, ... Clinical cancer research 21 (13), 3081-3091, 2015 | 168 | 2015 |
| Necrostatin-1 protects against reactive oxygen species (ROS)-induced hepatotoxicity in acetaminophen-induced acute liver failure K Takemoto, E Hatano, K Iwaisako, M Takeiri, N Noma, S Ohmae, ... FEBS open bio 4, 777-787, 2014 | 163 | 2014 |
| Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins I Ikai, Y Yamamoto, N Yamamoto, H Terajima, E Hatano, Y Shimahara, ... Surgical Oncology Clinics 12 (1), 65-75, 2003 | 157 | 2003 |
